CCDC200
gene geneOn this page
Summary
CCDC200 (coiled-coil domain containing 200, HGNC:43658) is a protein-coding gene on chromosome 17q21.31, encoding Coiled-coil domain-containing protein 200 (A0A1B0GVQ3).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_001363254
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43658 |
| Approved symbol | CCDC200 |
| Name | coiled-coil domain containing 200 |
| Location | 17q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000236383 |
| Ensembl biotype | protein_coding |
| Entrez | 100874261 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 9 nonsense_mediated_decay, 4 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000427995, ENST00000433702, ENST00000593624, ENST00000594691, ENST00000594857, ENST00000595400, ENST00000597948, ENST00000598128, ENST00000598568, ENST00000598934, ENST00000599491, ENST00000600764, ENST00000608223, ENST00000615433, ENST00000619529, ENST00000636331
RefSeq mRNA: 1 — MANE Select: NM_001363254
NM_001363254
CCDS: CCDS92329
Canonical transcript exons
ENST00000636331 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003196403 | 43224234 | 43224549 |
| ENSE00003797071 | 43228450 | 43228623 |
| ENSE00003797248 | 43223556 | 43223614 |
| ENSE00003936446 | 43221420 | 43221597 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 96.90.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 96.90 | gold quality |
| left testis | UBERON:0004533 | 96.62 | gold quality |
| testis | UBERON:0000473 | 95.76 | gold quality |
| sural nerve | UBERON:0015488 | 92.25 | gold quality |
| monocyte | CL:0000576 | 87.60 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.74 | gold quality |
| leukocyte | CL:0000738 | 86.58 | gold quality |
| kidney | UBERON:0002113 | 84.98 | gold quality |
| spleen | UBERON:0002106 | 84.66 | gold quality |
| cortex of kidney | UBERON:0001225 | 84.36 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 83.86 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.53 | gold quality |
| bone marrow cell | CL:0002092 | 83.19 | gold quality |
| blood | UBERON:0000178 | 82.78 | gold quality |
| granulocyte | CL:0000094 | 81.30 | gold quality |
| metanephros cortex | UBERON:0010533 | 81.28 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 81.09 | gold quality |
| ovary | UBERON:0000992 | 80.77 | gold quality |
| right ovary | UBERON:0002118 | 80.48 | gold quality |
| left ovary | UBERON:0002119 | 80.33 | gold quality |
| vermiform appendix | UBERON:0001154 | 79.97 | gold quality |
| bone marrow | UBERON:0002371 | 79.97 | gold quality |
| mucosa of stomach | UBERON:0001199 | 79.86 | gold quality |
| thyroid gland | UBERON:0002046 | 79.79 | gold quality |
| colonic epithelium | UBERON:0000397 | 79.63 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 79.62 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 79.55 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 79.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.02 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.01 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.07 |
| E-GEOD-111727 | no | 1249.54 |
| E-ENAD-27 | no | 4.28 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccdc200 | ENSMUSG00000085486 |
| rattus_norvegicus | Ccdc200 | ENSRNOG00000061008 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 200 — A0A1B0GVQ3 (reviewed: A0A1B0GVQ3)
All UniProt accessions (7): A0A1B0GVQ3, A0A1B0GTD9, A0A1B0GU98, A0A1B0GVJ5, A0A1B0GVX4, A0A1B0GVZ7, A0A1B0GW31
RefSeq proteins (1): NP_001350183* (*=MANE)
Domains & families (InterPro)
UniProt features (9 total): compositionally biased region 6, chain 1, region of interest 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GVQ3-F1 | 64.48 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 6 (showing top):
DESCARTES_FETAL_ADRENAL_MYELOID_CELLS, DESCARTES_FETAL_CEREBELLUM_MICROGLIA, DESCARTES_FETAL_CEREBRUM_MICROGLIA, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP, GENES_CORRELATED_WITH_RHOA_DELETION, chr17q21
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
68 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC200 | PEAK3 | Q6ZS72 | 571 |
| CCDC200 | THNSL2 | Q86YJ6 | 444 |
| CCDC200 | WDR72 | Q3MJ13 | 413 |
| CCDC200 | ARHGAP45 | Q92619 | 400 |
| CCDC200 | ADAMTSL2 | Q86TH1 | 396 |
| CCDC200 | AJAP1 | Q9UKB5 | 370 |
| CCDC200 | ZNF736 | B4DX44 | 366 |
| CCDC200 | ANO2 | Q9NQ90 | 356 |
| CCDC200 | HFM1 | A2PYH4 | 352 |
| CCDC200 | PTPN3 | P26045 | 336 |
| CCDC200 | CFAP20DC | Q6ZVT6 | 328 |
| CCDC200 | SGCG | Q13326 | 318 |
| CCDC200 | LEMD3 | Q9Y2U8 | 311 |
| CCDC200 | TMEM52 | Q8NDY8 | 311 |
| CCDC200 | METTL23 | Q86XA0 | 278 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GVQ3, A0A1W2PPK0, A0A1W2PPM1, A2A9I7, A6NCI8, A6QQS3, A7XCE8, E9PI22, E9PXT9, O15016, O91083, P09414, P0DMB1, P17923, P18804, P20879, P35965, P49750, Q0P670, Q12857, Q1RMX6, Q32LN6, Q32MG2, Q3B8N5, Q3T016, Q3V0A6, Q4JK59, Q5BI31, Q5T035, Q5ZKH6, Q642A3, Q6AXV6, Q6IMN6, Q6P1W5, Q6PEX7, Q6X4T0, Q80YD3, Q86UF4, Q8BII1, Q8C5V0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
343 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:43217258:GCAAA:G | acceptor_gain | 1.0000 |
| 17:43217313:G:GG | donor_gain | 1.0000 |
| 17:43217258:GCA:G | acceptor_gain | 0.9900 |
| 17:43217255:TCAG:T | acceptor_loss | 0.9800 |
| 17:43217257:A:AG | acceptor_gain | 0.9800 |
| 17:43217258:G:GG | acceptor_gain | 0.9800 |
| 17:43217258:GC:G | acceptor_gain | 0.9800 |
| 17:43217258:GCAA:G | acceptor_gain | 0.9800 |
| 17:43217260:A:AG | acceptor_gain | 0.9800 |
| 17:43216962:A:AG | acceptor_gain | 0.9700 |
| 17:43217261:A:G | acceptor_gain | 0.9700 |
| 17:43217309:TCCA:T | donor_gain | 0.9700 |
| 17:43217310:CCA:C | donor_gain | 0.9700 |
| 17:43217311:CA:C | donor_gain | 0.9600 |
| 17:43217308:ATCCA:A | donor_gain | 0.9500 |
| 17:43217311:CAGT:C | donor_loss | 0.9500 |
| 17:43217312:AG:A | donor_loss | 0.9500 |
| 17:43217313:G:A | donor_loss | 0.9500 |
| 17:43217314:TAAGT:T | donor_loss | 0.9500 |
| 17:43217315:AA:A | donor_loss | 0.9500 |
| 17:43217316:AG:A | donor_loss | 0.9500 |
| 17:43217317:G:C | donor_loss | 0.9400 |
| 17:43217650:GCCAT:G | acceptor_gain | 0.9300 |
| 17:43217056:G:GG | donor_gain | 0.8700 |
| 17:43217262:A:G | acceptor_gain | 0.8600 |
| 17:43217678:CA:C | acceptor_loss | 0.8300 |
| 17:43217680:G:T | acceptor_loss | 0.8300 |
| 17:43217679:AG:A | acceptor_gain | 0.8200 |
| 17:43217679:AGG:A | acceptor_gain | 0.8200 |
| 17:43217680:GG:G | acceptor_gain | 0.8200 |
AlphaMissense
1087 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:43221576:A:G | W168R | 0.988 |
| 17:43221576:A:T | W168R | 0.988 |
| 17:43221574:C:A | W168C | 0.974 |
| 17:43221574:C:G | W168C | 0.974 |
| 17:43221575:C:G | W168S | 0.945 |
| 17:43221575:C:A | W168L | 0.915 |
| 17:43221576:A:C | W168G | 0.823 |
| 17:43221577:C:A | Q167H | 0.766 |
| 17:43221577:C:G | Q167H | 0.766 |
| 17:43221596:G:A | S161F | 0.756 |
| 17:43221580:C:A | Q166H | 0.729 |
| 17:43221580:C:G | Q166H | 0.729 |
| 17:43221588:A:G | Y164H | 0.728 |
| 17:43221589:A:C | N163K | 0.703 |
| 17:43221589:A:T | N163K | 0.703 |
| 17:43221590:T:A | N163I | 0.668 |
| 17:43221587:T:G | Y164S | 0.657 |
| 17:43221588:A:C | Y164D | 0.603 |
| 17:43223560:A:G | L159P | 0.599 |
| 17:43221597:A:G | S161P | 0.597 |
| 17:43221588:A:T | Y164N | 0.579 |
| 17:43223556:C:A | K160N | 0.574 |
| 17:43223556:C:G | K160N | 0.574 |
| 17:43221578:T:G | Q167P | 0.569 |
dbSNP variants (sampled 300 via entrez): RS1000376047 (17:43223441 A>T), RS1000406989 (17:43226186 A>G), RS1001284195 (17:43221497 C>G), RS1001345434 (17:43222245 A>AACCTCC), RS1001952185 (17:43224405 G>A), RS1002680243 (17:43227178 C>T), RS1002684563 (17:43221406 C>G,T), RS1003111438 (17:43223165 C>T), RS1003128507 (17:43221046 TG>T), RS1003177392 (17:43226223 C>T), RS1003448861 (17:43221638 C>G), RS1003917507 (17:43226168 G>A), RS1004348082 (17:43226586 G>A), RS1004919639 (17:43224381 G>A), RS1005297491 (17:43221586 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002398_276 | Neutrophil count | 2.000000e-13 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004833 | neutrophil count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| dicrotophos | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| fipronil | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Oligomycins | increases expression | 1 |
| Rotenone | decreases expression, affects response to substance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.